0
0
10/24/23 at 10:59am
Organization
GlobeNewswire
Author
LianBio
37 words
0
Comments
LianBio to receive total upfront consideration of $350 millionLianBio Board of Directors to conduct strategic review of business SHANGHAI and...
You are the first to view
https://www.globenewswire.com/news-release/2023/10/24/2765435/0/en/LianBio-Enters-into-Agreement-with-Bristol-Myers-Squibb-for-Mavacamten-in-China-and-Other-Asian-Markets.html
Create an account
or login to join the discussion